ACC 2019: Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide - Prof Subodh Verma

Prof Subodh Verma (University of Toronto, Toronto, CA) discusses his poster presented at the ACC 2019 titled duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide - a post hoc analysis of the LEADER and SUSTAIN-6 Clinical Trials

Filmed on site at ACC 2019 by Radcliffe Cardiology

 

Videography: Josh Birch

Interviewer: Liam O'Neill

Video Category: 

  • Diabetes